Study Stopped
Unable to recruit patients due to technical issues following submission
Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)
The Evaluation of Intra-cardiac Shunts in Patients With Pulmonary Arteriovenous Malformations
1 other identifier
observational
N/A
1 country
1
Brief Summary
Pulmonary arteriovenous malformations (PAVMs) are thin-walled abnormal vessels which provide direct capillary-free communications between the pulmonary and systemic circulations. Patients with PAVMs have usually have low blood oxygen levels and are at risk of other complications including strokes, brain abscesses, pregnancy-related complications and haemorrhage. We hypothesise that the complications of PAVM patients arise from their PAVMs and not the more recognised intracardiac forms of shunting. We propose to perform echocardiograms to enable assessment of the presence of other causes of capillary-free communications between the pulmonary and systemic circulations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 12, 2008
CompletedFirst Posted
Study publicly available on registry
August 13, 2008
CompletedOctober 9, 2019
October 1, 2019
4.1 years
August 12, 2008
October 7, 2019
Conditions
Eligibility Criteria
Patients with pulmonary arteriovneous malformations
You may qualify if:
- patients with pulmonary arteriovenous malformations (PAVMs)
You may not qualify if:
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College Hammersmith Campus
London, W12 0NN, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Claire L Shovlin
Imperial College London
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2008
First Posted
August 13, 2008
Study Start
February 1, 2004
Primary Completion
March 1, 2008
Study Completion
March 1, 2008
Last Updated
October 9, 2019
Record last verified: 2019-10